Exagen, Inc. (XGN)
7.34
+0.31
(+4.41%)
USD |
NASDAQ |
Sep 14, 16:00
7.25
-0.09
(-1.23%)
After-Hours: 17:50
Exagen Price to Book Value : 14.54 for Sept. 14, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 13.92 |
| September 10, 2026 | 13.80 |
| September 09, 2026 | 14.48 |
| September 08, 2026 | 14.46 |
| September 04, 2026 | 15.01 |
| September 03, 2026 | 14.93 |
| September 02, 2026 | 14.87 |
| September 01, 2026 | 14.10 |
| August 31, 2026 | 14.54 |
| August 28, 2026 | 14.64 |
| August 27, 2026 | 14.89 |
| August 26, 2026 | 15.19 |
| August 25, 2026 | 15.05 |
| August 24, 2026 | 15.15 |
| August 21, 2026 | 15.68 |
| August 20, 2026 | 15.41 |
| August 19, 2026 | 14.71 |
| August 18, 2026 | 13.05 |
| August 17, 2026 | 13.27 |
| August 14, 2026 | 13.19 |
| August 13, 2026 | 13.03 |
| August 12, 2026 | 13.05 |
| August 11, 2026 | 13.41 |
| August 10, 2026 | 13.15 |
| August 07, 2026 | 13.61 |
| Date | Value |
|---|---|
| August 06, 2026 | 13.05 |
| August 05, 2026 | 13.17 |
| August 04, 2026 | 12.77 |
| August 03, 2026 | 9.268 |
| July 31, 2026 | 8.971 |
| July 30, 2026 | 9.249 |
| July 29, 2026 | 8.615 |
| July 28, 2026 | 8.813 |
| July 27, 2026 | 8.714 |
| July 24, 2026 | 9.268 |
| July 23, 2026 | 9.803 |
| July 22, 2026 | 9.783 |
| July 21, 2026 | 9.625 |
| July 20, 2026 | 9.268 |
| July 17, 2026 | 8.694 |
| July 16, 2026 | 8.417 |
| July 15, 2026 | 8.516 |
| July 14, 2026 | 8.100 |
| July 13, 2026 | 8.199 |
| July 10, 2026 | 8.813 |
| July 09, 2026 | 9.150 |
| July 08, 2026 | 8.635 |
| July 07, 2026 | 9.506 |
| July 06, 2026 | 8.714 |
| July 02, 2026 | 8.991 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Myriad Genetics, Inc. | 1.197 |
| BioRestorative Therapies, Inc. | 1.137 |
| CareDx, Inc. | 6.333 |
| Natera, Inc. | 26.95 |
| Sera Prognostics, Inc. | 1.328 |
Price to Book Value Related Metrics
| PS Ratio | 2.439 |
| Price | 7.34 |
| Earnings Yield | -10.98% |
| Market Cap | 177.58M |